Results 101 to 110 of about 31,835 (290)

Case Report: Two instances of lung metastasis in low-grade endometrial stromal sarcoma

open access: yesFrontiers in Oncology
BackgroundLow-grade endometrial stromal sarcoma (LGESS) with pulmonary metastasis is a rare malignant mesenchymal tumor. LGESS is composed of cells resembling proliferative endometrial stromal cells.
Anying Long   +4 more
doaj   +1 more source

Retrospective Analysis of Master Protocols in Tumor‐Agnostic Drug Development: Evaluation of Application to Single‐Agent Therapies With ORR as the Endpoint for Approval of Oncology Drugs

open access: yesClinical and Translational Science, Volume 18, Issue 8, August 2025.
ABSTRACT The first global approval of a microsatellite instability‐high solid tumors was a landmark in oncology, paving the way for targeted therapies approved globally. However, guidance remains limited regarding the biological and methodological conditions under which such designs, statistical borrowing, are most effective.
Keiko Yamamoto   +2 more
wiley   +1 more source

Cellular retinol-binding protein-1 expression in endometrial stromal cells: physiopathological and diagnostic implications [PDF]

open access: yes, 2004
Cellular retinol-binding protein-1 (CRBP-1) contributes to the maintenance of the differentiated state of the endometrium through retinol bioavailability regulation.
Ciucci, A   +7 more
core   +1 more source

Human sporadic breast carcinoma histotypes driven by the Human Betaretrovirus homologous to Mouse Mammary Tumor Virus

open access: yesInternational Journal of Cancer, Volume 157, Issue 2, Page 371-383, 15 July 2025.
What's new? While estrogens, obesity, and alcohol are recognized risk factors for breast cancer, a viral hypothesis has been suggested based on the murine model of Mouse Mammary Tumor Virus (MMTV)‐induced mammary tumors. This study analyzed sequences of the human homolog of MMTV across human breast carcinoma histotypes, detecting the virus in all types
Prospero Civita   +12 more
wiley   +1 more source

Systemic therapy for endometrial stromal sarcomas: current treatment options [PDF]

open access: yes, 2016
Uterine endometrial stromal sarcomas including true low-grade endometrial stromal sarcoma (LG-ESS) and high-grade (HG-ESS) or undifferentiated endometrial sarcoma (UES) constitute a group of rare, aggressive malignancies.
Jassem, Jacek   +2 more
core   +2 more sources

Combating cancer immunotherapy resistance: a nano‐medicine perspective

open access: yesCancer Communications, Volume 45, Issue 7, Page 813-840, July 2025.
Abstract Cancer immunotherapy offers renewed hope for treating this disease. However, cancer cells possess inherent mechanisms that enable them to circumvent each stage of the immune cycle, thereby evading anti‐cancer immunity and leading to resistance.
Xiangyi Kong   +10 more
wiley   +1 more source

A case of Low-grade endometrial stromal sarcoma with multiple metastasis [PDF]

open access: yes, 2006
Uterine sarcomas are rare tumors of mesodermal origin and constitute 2-6% of uterine malignancies. They are classified into leiomyosarcoma (LMS), malignant mixed mullerian tumors (MMMTs), and endometrial stromal sarcoma (ESS) by histologic types ...
김성훈   +5 more
core  

A Case of Retroperitoneal Metastases That Occur 14 Years After Surgery

open access: yesUrology Case Reports, 2016
Endometrial Stromal Sarcomas are rare malignant tumours of the uterus. We report the case of incidental finding of Low-Grade Endometrial Stromal Sarcoma (LGESS) that metastasized to the retroperitoneum 14 years after the original surgery in a 72-year-old
Masjensen Argadjendra   +2 more
doaj   +1 more source

Executive Summary of the American Radium Society Appropriate Use Criteria for the Management of Peritoneal Carcinomatosis From Different Tumor Origins: Systematic Review and Guidelines

open access: yesCancer Medicine, Volume 14, Issue 14, July 2025.
ABSTRACT Background Multimodality therapy incorporating a combination of cytoreductive surgery (CRS), intraperitoneal (IP) and systemic therapy continues to evolve for peritoneal carcinomatosis (PC) However, treatment and outcomes vary depending on tumor of origin.
Expert Panel Management of Peritoneal Carcinomatosis   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy